Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-03-14 @ 6:35 AM
Study NCT ID:
NCT00354120
Status:
COMPLETED
Last Update Posted:
2023-03-10
First Post:
2006-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant
Sponsor:
Gruppo Italiano Trapianto di Midollo Osseo
Organization: